Otonomy
ClosedSan Diego, United States · Founded 2008
- Headquarters
- San Diego
- Employees
- 51–200
- Founded
- 2008
- Business Model
- B2B2C
- Website
- otonomy.com
About
Otonomy, Inc. was a San Diego-based, publicly traded (Nasdaq: OTIC) biopharmaceutical company founded in 2008 that developed innovative therapeutics for diseases and disorders of the middle and inner ear, including tinnitus, Meniere's disease, and hearing loss, using a sustained-exposure drug delivery technology administered via direct otic injection. After lead candidates OTO-413 and OTO-825 failed to meet clinical trial endpoints in 2022, the company laid off its entire staff in December 2022 and its board approved a plan to liquidate, dissolve, and distribute remaining cash to shareholders.
Summary
Otonomy is a Biotech company based in San Diego, United States, founded in 2008.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/otonomy"><img src="https://indexed.vc/api/badge/company/otonomy" alt="Otonomy on Indexed.vc" width="260" height="76" /></a>